| 000 | 00956 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514004422.0 | ||
| 264 | 0 | _c20011211 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1172-7047 | ||
| 024 | 7 |
_a10.2165/00023210-200115050-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aImbimbo, B P | |
| 245 | 0 | 0 |
_aPharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. _h[electronic resource] |
| 260 |
_bCNS drugs _c2001 |
||
| 300 |
_a375-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tCNS drugs _gvol. 15 _gno. 5 _gp. 375-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00023210-200115050-00004 _zAvailable from publisher's website |
| 999 |
_c11403268 _d11403268 |
||